|
VOLUME 33: NO. 6 JUNE 2006
Editorials
Patient Empowerment: Rofecoxib Revisited
 H. Tannenbaum .........1033
Impaired Hypothalamic Function, Prolactinomas, and Autoimmune Diseases
 S.E. Walker .........1036
Nonthrombotic Manifestations of the Antiphospholipid Syndrome: Away from Thrombosis?
 R.A. Asherson, R. Cervera, D. Shepshelovich,
Y. Shoenfeld .........1038
Whiplash and Fibromyalgia: An Ever-Widening Gap
 Y. Shir, J.X. Pereira, M-A. Fitzcharles .........1045
Articles
SUMO4 and MAP3K7IP2 SNP and Susceptibility to RA
 J. Costas, E. Perez-Pampin, I. Ferreiros-Vidal, et al .........1048
Trichostatin A Cooperates with Fas-Mediated Signal to Induce Apoptosis in RA Synovial Fibroblasts
 A. Morinobu, B. Wang, J. Liu, S. Yoshiya, M. Kurosaka,
S. Kumagai .........1052
TNF-α Protects Synovial Cells from NO Induced Apoptosis Through PI3K Akt Signal Transduction
 Q. Chen, B. Casali, L. Pattacini, L. Boiardi,
C. Salvarani .........1061
Socioeconomic Status and Risk of RA: A Danish Case-Control Study
 M. Pedersen, S. Jacobsen, M. Klarlund,
M. Frisch .........1069
Adalimumab for Treating RA
 F. Navarro-Sarabia, R. Ariza-Ariza, B. Hernández-Cruz,
I. Villanueva .........1075
The Patient's Perspective on the Recall of Vioxx
 G.A. Hawker, J.N. Katz, D.H. Solomon .........1082
The Prodrome: A Prominent Yet Overlooked Pre-Attack Manifestation of Familial Mediterranean Fever
 M. Lidar, M. Yaqubov, N. Zaks, S. Ben-Horin,
P. Langevitz, A. Livneh .........1089
Differential Expression of Estrogen Receptors in Women with SLE
 V. Rider, X. Li, G. Peterson,
J. Dawson, B.F. Kimler, N.I. Abdou .........1093
Abnormal Telomerase Activity and Telomere Length in T and B Cells from Patients with SLE
 D. Kurosaka, J. Yasuda, K. Yoshida, et al .........1102
Functional Hyperprolactinemia and Hypophyseal Microadenoma in SSc
 O. Vera-Lastra, L.J. Jara, G. Medina, et al .........1108
A Cohort Study of Cancer Incidence in SSc
 C.T. Derk, M. Rasheed, C.M. Artlett, S.A. Jimenez .........1113
Quality of Life and Functional Status in SSc
Compared to Other Rheumatic Diseases
 S.R. Johnson, D.D. Gladman, C.T. Schentag,
P. Lee .........1117
Scleroderma: Health Services Utilization from
Patients' Perspective
 S.R. Johnson, S. Carette, J.V. Dunne .........1123
Quantitative Measurement of HLA-B27 mRNA in Patients with AS Correlation with Clinical Activity
 S-Q. Liu, H-C. Yu, Y-Z. Gong, N-S. Lai .........1128
Precocious OA in a Family with Recurrent COL2A1 Mutation
 K.M. Carlson, K.M. Yamaga, K.A. Reinker, et al .........1133
Can the CMC Joint Be Injected Accurately in the Office Setting? Implications for Therapy
 L.A. Mandl,
R.N. Hotchkiss, R.S. Adler, L.A. Ariola, J.N. Katz .........1137
Insufficiency Fractures of the Calcaneus: A Diagnostic Pitfall for Ankle Arthritis
 P. Alonso-Bartolome, R. Blanco,
A. Canga, V.M. Martínez-Taboada .........1140
Accuracy and Dispersal of Subacromial and Glenohumeral Injections in Cadavers
 N. Hanchard, D. Shanahan, T. Howe, J. Thompson,
L. Goodchild .........1143
Associations Between JSN and Molecular Markers of Collagen and Proteoglycan Turnover in Patients with Knee OA
 S.A. Mazzuca, A.R. Poole, K.D. Brandt,
B.P. Katz, K.A. Lane, T. Lobanok .........1147
Direct and Indirect Costs Attributable to OA in Active Subjects
 V. Rabenda, C. Manette, R. Lemmens,
A-M. Mariani, N. Struvay, J-Y. Reginster .........1152
Extent of Followup Care After Elective Total Hip Replacement
 P. de Pablo, E. Losina, N. Mahomed, et al .........1159
Implication of Prostaglandin Receptors in the Accumulation of Osteoprotegerin in Human
Osteoblast Cultures
 R. Samadfam, M.A. Gallant, M-C. Miousse,
J-L. Parent, A.J. de Brum-Fernandes .........1167
Licofelone Reduces Progression of Structural Changes in a Canine Model of OA Under Curative Conditions: Effect on Protease Expression and Activity
 M. Moreau, C. Boileau, J. Martel-Pelletier, J. Brunet,
S. Laufer, J-P. Pelletier .........1176
Neck Injury and FM Are They Really Associated?
 M. Tishler, O. Levy, I. Maslakov, S. Bar-Chaim,
M. Amit-Vazina .........1183
Pediatric Rheumatology
Radiologic Improvement of Juvenile Idiopathic Arthritis-Enthesitis-Related Arthritis Following
Anti-TNF-a Blockade with Etanercept
 S.M.L. Tse, R.M. Laxer, P.S. Babyn, A.S. Doria .........1186
Case Reports
Interstitial Pneumonitis Associated with Infliximab Therapy
 E. Villeneuve, A. St-Pierre, B. Haraoui .........1189
Rituximab Treatment of Thrombotic Thrombocytopenic Purpura in the Setting of Connective Tissue Disease
 T.B. Niewold, D. Alpert, C.R. Scanzello, S.A. Paget .........1194
Treatment of Cryoglobulinemia Associated Peripheral Neuropathy with Rituximab
 F.Z.J. Cai, M. Ahern, M. Smith .........1197
Coexistent Marfan's Syndrome and AS
 C. Kiss, I. Jónap, P. Gergely Jr., G. Poór .........1199
Correspondence
Dexamethasone: An "Old New" Glucocorticoid on the Horizon!
E-J.A. Kroot, M.A.M. Huisman .........1201
Reply
F. Buttgereit .........1201
Letters
Etanercept Induced Multiple Sclerosis and
Transverse Myelitis
 N. Al Saieg, M.J. Luzar .........1202
Usefulness of Angioplasty in a Patient with Biopsy-Proven GCA and Severe Stenosis of the Superior Mesenteric Artery
S. Serradell, A. Laiz, C. Castaño, J.M. de Llobet .........1204
Development of PMR in Patients with Scleroderma
I.M. Orzano, E.V. Lally .........1206
Interstitial Granulomatous Dermatitis with Arthritis (Ackerman Syndrome)
N. Busquets-Pérez,
J. Narvaez, J. Valverde-García .........1207
Granulomatous Uveitis Revealing Wegener's Granulomatosis
D.L.T. Huong, T.H.C. Tran, J-C. Piette .........1209
A Boy with Fever and Whorl Keratopathy
C. Halligan, B.A. Heese, G. Mellor, V.V. Michels,
A. Reed .........1210
Meetings in Rheumatology
|